ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Arno Therapeutics Inc (CE)

Arno Therapeutics Inc (CE) (ARNI)

0.0001
0.00
(0.00%)
Closed January 27 3:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000058 52 Week Range 0.0003
Previous Close
0.0001
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
800
Financial Volume
-
VWAP
-

ARNI Latest News

Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...

FLEMINGTON, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

FLEMINGTON, N.J., May 29, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports First Quarter 2014 Financial and Business Update

FLEMINGTON, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...

Studies to determine recommended Phase II dose and safety profile of lead compound Will analyze relationship of biomarker to any anti-tumor activity observed FLEMINGTON, N.J., May 14, 2014...

Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual Meeting

FLEMINGTON, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...

FLEMINGTON, N.J., April 7, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational Milestones

FLEMINGTON, N.J., April 1, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014...

FLEMINGTON, N.J., March 26, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman

FLEMINGTON, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at 26th Annual ROTH Conference

FLEMINGTON, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
12000.00010.00010.00018000.0001CS
26-0.0002-66.66666666670.00030.00030.000174920.0001CS
524.2E-572.41379310345.8E-50.00035.8E-537570.00012027CS
156-0.002-95.23809523810.00210.00211.0E-665097.433E-5CS
260-0.0016-94.11764705880.00170.0421.0E-6644990.00498007CS

ARNI - Frequently Asked Questions (FAQ)

What is the current Arno Therapeutics (CE) share price?
The current share price of Arno Therapeutics (CE) is US$ 0.0001
What is the 1 year trading range for Arno Therapeutics (CE) share price?
Arno Therapeutics (CE) has traded in the range of US$ 0.000058 to US$ 0.0003 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TGICTriad Guaranty Inc (CE)
US$ 0.05
(49,900.00%)
1.4k
NOUVNouveau Life Pharmaceuticals Inc (PK)
US$ 0.0002
(19,900.00%)
4.31M
ATYGAtlas Technology Group Inc (PK)
US$ 0.0002
(19,900.00%)
9k
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0.0002
(19,900.00%)
255
ONCIOn4 Communications Inc (PK)
US$ 0.0001
(9,900.00%)
16.82M
SPECSpectaire Holdings Inc (CE)
US$ 0.000001
(-99.95%)
1.99k
TMPOQTempo Automation Holdings Inc (CE)
US$ 0.000001
(-99.89%)
452
FUVVArcimoto Inc (CE)
US$ 0.000001
(-99.50%)
336
SAFSSafer Shot Inc (CE)
US$ 0.000001
(-99.00%)
2M
JAMNJammin Java Corp (PK)
US$ 0.000001
(-99.00%)
39k
TKMOTekumo Inc (PK)
US$ 0.0004
(0.00%)
244.5M
HMBLHUMBL Inc (PK)
US$ 0.00075
(-6.25%)
219.57M
PDGOParadigm Oil and Gas Inc (PK)
US$ 0.0002
(33.33%)
215.18M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.000001
(-99.00%)
195.11M
DPLSDarkPulse Inc (PK)
US$ 0.0006
(-14.29%)
182.43M

Discussion

View Full Feed
thistraderknowsall thistraderknowsall 3 minutes ago
GREAT NEWS!!!!! .01 Tomorrow!!!!!
Forget about the past ....The future is alot
Brighter!!!!!+ CONGRATS!!!++ WE WIN!!
DBMM
threewheeler threewheeler 3 minutes ago
if no one buys the shells guess they not gonna get em Current
moondogaz moondogaz 3 minutes ago
More like harpooning.
HMBL
malexa00 malexa00 5 minutes ago
Uh, and where did you see that AIG is a multi-billion company?
LOL. It has like one employee
AIG
12yearplan 12yearplan 5 minutes ago
Let's hang around and watch shall we ;)..
Acme Investments Acme Investments 5 minutes ago
You must be new here!! This is about the 10th time it's had a day spike!! The same thing happened they diluted into it and killed the momentum!! I don't believe you're buying anything!!
TKMO
ZRock ZRock 5 minutes ago
you conveniently left something out of your post..

Egg prices have steadily risen in recent months due to a spike in bird flu; outbreaks in egg-laying chickens are affecting the national supply, driving up costs. Holiday baking and cold-weather stockpiling also increased demand, and
Fully Diluted Fully Diluted 6 minutes ago
Exactly, Nats,

Pulte's hearing will be all about the GSE's. And Pulte won't go out on a limb and make vague announcements to get him confirmed. He will most certainly be asked about working with Congress. Bessent has already given a foretaste of what Pulte can say:

„Que
FNMA
jglider jglider 6 minutes ago
what did I just say about cycles and news? Have never been able to fully explain it.
mascale mascale 7 minutes ago
Anyone notes usual waterchaser poster illiteracy, posted!
HIRU
GrantHorvat1 GrantHorvat1 7 minutes ago
Why?

I talked to him the other day.

I guess you can email me if it's important.
jog49 jog49 8 minutes ago
"Scott “I'll end the conservatorships, work with Ackman on it and cancel the SPS” Bessent is now Treasury Secretary. Holy moly!"


Do Not Hold Your Breath. I repeat Do Not Holf Your Breath!
FNMA
Jetmek_03052 Jetmek_03052 8 minutes ago
Looks like people are already seeing how they foolishly lost their minds today. Futures on the way back up.
NVDA
JJ8 JJ8 9 minutes ago
Added Alphabet shares at $193.15. GLTA
Average cost per share at this time: $149.50
GOOG
Zorax Zorax 10 minutes ago
If they make another disney Cruella De Vil movie, they should hire Melania, she's a natural in looks and personality. Doesn't even need make up.
Clark6290 Clark6290 10 minutes ago
All just wishful thinking. You cannot really believe he will be working with Ackman on release. Pure fantasy land.
FNMA
NoMoDo NoMoDo 10 minutes ago
I was fishing for a confirmation. Thanks.
HMBL
Dennis14 Dennis14 11 minutes ago
https://www.biospace.com/press-releases/igc-pharma-names-igc-ad1-phase-2-clinical-trial-for-alzheimers-agitation-calma-and-expands-recruitment-strategy As of January 8 2025
IGC
Zorax Zorax 11 minutes ago
Another one bites the dust...hut hut...

https://www.fox32chicago.com/news/indiana-man-fatally-shot-deputy-identified-jan-6
NoMoDo NoMoDo 11 minutes ago
You would do anything to keep me investing in that other one. You work for the company shorting this one too?
MULN
janice shell janice shell 12 minutes ago
Maybe. I don't really know.
BOREALIS BOREALIS 12 minutes ago
FACT FOCUS: A look at false and misleading claims made by Trump during his first week back in office

By MELISSA GOLDIN
Updated 4:48 PM CST, January 24, 2025

President Donald Trump stepped back into the presidency this week moving quickly to set a new agenda, but
NoMoDo NoMoDo 12 minutes ago
The name comes from my inability to stop buying shares when I see that the value of a company is higher than the share price. Likely no relationship with this stock.
MULN
janice shell janice shell 12 minutes ago
Yes. The worst.
getmoreshares getmoreshares 13 minutes ago
week is just starting!!!!!!!!!!!!!!! Good to see you back! 😎😎😎 GOLD GOLD GOLD!
NBRI

Your Recent History

Delayed Upgrade Clock